|
1
|
Nourse MB, Halpin DE, Scatena M, et al:
VEGF induces differentiation of functional endothelium from human
embryonic stem cells: implications for tissue engineering.
Arterioscler Thromb Vasc Biol. 30:80–89. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Avraham-Davidi I, Yona S, Grunewald M,
Landsman L, Cochain C, Silvestre JS, Mizrahi H, Faroja M,
Strauss-Ayali D, Mack M, et al: On-site education of VEGF-recruited
monocytes improves their performance as angiogenic and arteriogenic
accessory cells. J Exp Med,. 210:2611–2625. 2013. View Article : Google Scholar
|
|
3
|
Park JJ, Hwang SJ, Park JH and Lee HJ:
Chlorogenic acid inhibits hypoxia-induced angiogenesis via
down-regulation of the HIF-1α/AKT pathway. Cell Oncol (Dordr).
38:111–118. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kim YJ, Choi WI, Jeon BN, Choi KC, Kim K,
Kim TJ, Ham J, Jang HJ, Kang KS and Ko H: Stereospecific effects of
ginsenoside 20-Rg3 inhibits TGF-β1-induced epithelial-mesenchymal
transition and suppresses lung cancer migration, invasion and
anoikis resistance. Toxicology. 322:23–33. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fang Z: Study on PI3K as an anti-cancer
angiogenesis and vascular mimicry common targets (unpublished PhD
thesis). Huazhong University of Science and Technology. 2010.
|
|
6
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
World Health Organization: Latest world
cancer statistics: Global cancer burden rises to 14.1 million new
cases in 2012: Marked increase in breast cancers must be addressed.
WHO; Geneva: 2013
|
|
8
|
Cantley LC: The phosphoinositide 3-kinase
pathway. Science. 296:1655–1657. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liao DW, Wang L, Zhang XG and Liu MQ:
Expression and significance of PTEN/PI3K signal
transduction-related proteins in non-small cell lung cancer. Ai
Zheng. 25:1238–1242. 2006.(In Chinese). PubMed/NCBI
|
|
10
|
Zhang Q, Tang X, Zhang ZF, Velikina R, Shi
S and Le AD: Nicotine induces hypoxia-inducible factor-1alpha
expression in human lung cancer cells via nicotinic acetylcholine
receptor-mediated signaling pathways. Clin Cancer Res.
13:4686–4694. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Savai R, Schermuly RT, Voswinckel R,
Renigunta A, Reichmann B, Eul B, Grimminger F, Seeger W, Rose F and
Hänze J: HIF-1α attenuates tumor growth in spite of augmented
vascularization in an A549 adenocarcinoma mouse model. Int J Oncol.
27:393–400. 2005.PubMed/NCBI
|
|
12
|
Abid MR, Guo S, Minami T, Spokes KC, Ueki
K, Skurk C, Walsh K and Aird WC: Vascular endothelial growth factor
activates PI3K/Akt/forkhead signaling in endothelial cells.
Arterioscler Thromb Vasc Biol. 24:294–300. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wu S, Cheng Z, Yu L, Song W and Tao Y:
Expression of CD82/KAI1 and HIF-1α in non-small cell lung cancer
and their relationship to vasculogenic mimicry. Zhongguo Fei Ai Za
Zhi. 14:918–925. 2011.(In Chinese). PubMed/NCBI
|
|
14
|
Han Y, Jing W, Wang G and Ao Q: Lung
cancer angiogenesis mimicry and expression and significance of
HIF-lα. J Clin Exp Pathol. 24:269–272. 2008.(In Chinese). doi:
10.13315/j.cnki.cjcep.2008.03.011.
|
|
15
|
Chetty C, Lakka SS, Bhoopathi P and Rao
JS: MMP-2 alters VEGF expression via alphaVbeta3 integrin-mediated
PI3K/AKT signaling in A549 lung cancer cells. Int J Cancer.
127:1081–1095. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Khoufache K, Bazin S, Girard K,
Guillemette J, Roy MC, Verreault JP, Al-Abed Y, Foster W and Akoum
A: Macrophage migration inhibitory factor antagonist blocks the
development of endometriosis in vivo. PLoS One. 7:e372642012.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Munagala R, Aqil F and Gupta RC: Promising
molecular targeted therapies in breast cancer. Indian J Pharmacol.
43:236–245. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Le Tourneau C, Faivre S, Serova M and
Raymond E: mTORC1 inhibitors: Is temsirolimus in renal cancer
telling us how they really work? Br J Cancer. 99:1197–1203. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ji Y, Chen S, Li K, Li L, Xu C and Xiang
B: Signaling pathways in the development of infantile hemangioma. J
Hematol Oncol. 7:132014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kaessmeyer S, Bhoola K, Baltic S, Thompson
P and Plendl J: Lung cancer neovascularisation: Cellular and
molecular interaction between endothelial and lung cancer cells.
Immunobiology. 219:308–314. 2014. View Article : Google Scholar : PubMed/NCBI
|
